-transparent.png){kind=logo}
Growth of Candida albicans can be inhibited by sulfa drugs which prevent biosynthesis of folic acid. The dihydrofolate reductase (E.C. 1.5.1.3) inhibitors aminopterin and methotrexate also exhibit anticandidal activity, but trimethoprim does not. Kinetic evaluations with C. albicans dihydrofolate reductase indicate that methotrexate and aminopterin are tight-binding inhibitors whereas trimethoprim binds poorly.
Related Publications
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
January 1989,
The Journal of biological chemistry,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
September 1995,
Journal of medicinal chemistry,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
November 2022,
Journal of biomolecular structure & dynamics,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
June 2014,
Journal of enzyme inhibition and medicinal chemistry,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
May 1991,
FEMS microbiology letters,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
February 2002,
Journal of medical microbiology,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
January 1981,
Medicinal research reviews,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
September 1994,
Gene,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
March 2018,
Antimicrobial agents and chemotherapy,
K Bush, and
J S Freudenberger, and
D S Slusarchyk, and
R B Sykes, and
E Meyers
December 1993,
Journal of chemotherapy (Florence, Italy),
